Boston Scientific (BSX) Operating Expenses (2009 - 2026)

Boston Scientific (BSX) has 18 years of Operating Expenses data on file, last reported at $2.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 9.83% year-over-year to $2.5 billion; the trailing twelve-month figure through Mar 2026 stood at $10.5 billion (up 13.74% YoY), and the FY2025 full-year result was $10.2 billion, up 15.24% from the prior year.
• Operating Expenses retreated to $2.5 billion in Q1 2026, from $2.9 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.9 billion in Q4 2025 to a low of $1.6 billion in Q1 2022.
• A 5-year average of $2.1 billion and a median of $2.0 billion in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses slipped 7.34% in 2022 and gained 24.87% in 2024, its largest moves.
• Tracing BSX's Operating Expenses over 5 years: stood at $1.8 billion in 2022, then climbed by 9.02% to $2.0 billion in 2023, then advanced by 21.3% to $2.4 billion in 2024, then grew by 17.93% to $2.9 billion in 2025, then slipped by 11.95% to $2.5 billion in 2026.
• Business Quant data shows BSX's Operating Expenses at $2.5 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.5 billion in Q3 2025.